19 citations
,
January 2017 in “Hormone Molecular Biology and Clinical Investigation” This study found a high prevalence of hyperandrogenemia in women with PCOS, with distinct biochemical differences according to BMI and presence of hyperandrogenemia.
18 citations
,
September 2020 in “BMC Public Health” This study found that non-Kuwaiti COVID-19 patients in Kuwait had higher odds of death, ICU admission, ARDS, and pneumonia compared to Kuwaiti patients.
10 citations
,
October 2014 in “Journal of Ovarian Research” This study found a significant association between the IRS-2 gene variant and an increased risk of PCOS, especially in non-obese women in the Chinese population from Taiwan.
5 citations
,
January 2024 in “Journal of Primary Care & Community Health” This study observed that the severity of long COVID symptoms varies among patients and sociodemographic and clinical factors affect the likelihood of experiencing symptoms for more than a year. Understanding these factors may optimize management and improve patient outcomes.
2 citations
,
February 2023 in “BMC women's health” In this study, oral contraceptive use in women with PCOS increased the expression of certain inflammatory gene markers, which were positively associated with metabolic abnormalities.
August 2026 in “The Laryngoscope” This study found that adults with type 2 diabetes or obesity using semaglutide and tirzepatide experienced higher odds of nonscarring alopecia, such as telogen effluvium, compared to those using other GLP-1 receptor agonists, with hair loss potentially linked to physiologic stress from weight loss.
August 2008 in “European Neuropsychopharmacology” This study identified significant correlations between self-esteem, psychiatric symptoms, and health-related quality of life in peritoneal dialysis patients.
September 2024 in “South Eastern European Journal of Public Health” This study found that a treatment regimen including dietary changes, oral contraceptives, fertility drugs, Glucophage or Metformin, and nutritional supplements significantly improved hormonal and immune markers and reduced clinical symptoms like ovulation and menstrual disorders in PCOS patients over three months.
February 2017 in “The Journal of Sexual Medicine” This study found that young men using finasteride for androgenic alopecia exhibited erectile tissue fibrosis and associated sexual dysfunction, including low libido and mood changes.
1 citations
,
June 2019 in “Current developments in nutrition” This case study reports that pancreatic enzyme replacement and fatty acid supplementation improved symptoms of fat malabsorption and essential fatty acid deficiency in a patient with EDS-4.
January 2025 in “Dermatology Practical & Conceptual” This study observed that post-COVID-19 telogen effluvium is more common among those with anemia, but was not linked to the severity of the initial infection.
April 2023 in “The journal of investigative dermatology/Journal of investigative dermatology” This study found that phototherapy was more effective for patients with the multiple or totalis types of alopecia areata, with whole-body phototherapy potentially benefiting those with refractory universalis type.
September 2002 in “Fertility and sterility” This study found that metformin therapy is associated with the initiation of ovulatory cycles in women with PCOS and a trend toward reduced 17P responses after six months, but did not improve hirsutism or body composition.
62 citations
,
June 2023 in “Acta Dermato Venereologica” This observational study found that patients with various skin diseases across 17 European countries experience higher levels of perceived stigmatization than skin-healthy controls, particularly those with psoriasis, atopic dermatitis, alopecia, and bullous disorders, with factors such as disease severity and psychological distress influencing stigmatization levels.
2 citations
,
July 2024 in “Ibn AL- Haitham Journal For Pure and Applied Science” This study found that PCOS women with COVID-19 had lower ACE2 levels and higher insulin resistance, suggesting increased cardiovascular risk.
July 2026 in “Frontiers in Medicine” This study reported normative ranges for uterine and ovarian dimensions in Indian women aged 18–40, noting correlations with anthropometric and hormonal factors. These findings aim to improve diagnosis and management of reproductive health disorders in this population.
June 2026 in “IP Indian Journal of Clinical and Experimental Dermatology” This study found that trichoscopic parameters in male androgenetic alopecia deteriorated progressively with increasing disease severity and were significantly linked to genetic, metabolic, and psychosocial factors.
July 2024 in “Health Science Reports” In this retrospective study, remdesivir was administered on an outpatient basis to Covid-19 patients, showing effectiveness with low side effects. Early administration improved outcomes, corticosteroids had limited benefits, and body mass index did not significantly impact hospitalization rates.
May 2023 in “Frontiers in Endocrinology” This study found that tildacerfont treatment in males with congenital adrenal hyperplasia reduced androgen levels and improved markers of testicular function, suggesting potential benefits for male reproductive health.
34 citations
,
February 2013 in “The Journal of Clinical Endocrinology and Metabolism” This study estimates the prevalence of hyperandrogenic states in late adolescent and young females, revealing that these disorders often begin at a young age.
August 2023 in “İzmir tepecik eğitim hastanesi dergisi” This study suggests that the role of vitamin 25(OH)D in the pathogenesis of PCOS and diminished ovarian reserve may be independent of serum vitamin 25(OH)D levels.
162 citations
,
January 2015 in “Trends in Endocrinology and Metabolism” This review discusses how women with PCOS have an increased risk of insulin resistance and cardiometabolic features regardless of body fat, and calls for targeted prevention and management strategies.
2 citations
,
November 2017 in “Cardiovascular endocrinology” This study found that androgenic alopecia is the strongest predictor of coronary artery disease in young men from Western India, followed by premature graying and obesity.
April 2025 in “Journal of Clinical Medicine” In this study, women with suspected PCOS who reduced their intake of sweets, fatty red meat, and alcohol for over 6 months showed significantly lower total testosterone levels compared to those who did not, highlighting the benefit of targeted dietary changes on hormonal profiles.
May 2023 in “Journal of Cosmetic Dermatology” This study found that obese and overweight children have higher prevalence of certain skin disorders like keratosis pilaris and acanthosis nigricans, with these conditions being linked to insulin resistance and more likely in children with darker skin tones.
50 citations
,
August 2017 in “Diabetologia” This review discusses genetic factors that may influence the effectiveness of metformin in treating polycystic ovary syndrome and emphasizes the need for further research to establish clear benefits.
22 citations
,
September 2015 in “Fertility and Sterility” In this study, abnormal glucose tolerance was found to be prevalent among young Indian women with PCOS, and the use of an oral glucose tolerance test significantly improved its detection.
November 2013 in “대한피부과학회지” This study observed that eating habits differed among male AGA patients, particularly those with a longer disease duration showing a higher intake of meat but lower intake of fish compared to those with shorter duration.
May 2018 in “Endocrine Abstracts” SFRP-4 might be an early indicator of diabetes and hypertension in men with androgenic alopecia.
308 citations
,
December 2018 in “PLOS Genetics” This study identified three novel genetic loci associated with PCOS and found similar genetic architecture across different diagnostic criteria, with evidence suggesting genetic links between PCOS and various metabolic and psychological traits.